The World Health Organization’s International Agency for Research on Cancer (IARC) has projected a significant rise in global cancer cases, estimating over 35 million new cases by 2050.
This represents a 77% increase from the 20 million cases diagnosed in 2022.
The IARC’s report, which gathers data from 185 countries across 36 cancer types, also highlights the concerning trend of 9.7 million cancer-related deaths in 2022.
It blamed ‘lifestyle factors’ such as tobacco and alcohol use, obesity, and poor air quality are major contributors to the anticipated surge.
The report reveals a stark disparity in cancer diagnoses across different regions, with lower income areas expected to experience more than a doubling of cancer cases.
Lung and breast cancer remain the most common types among men and women, respectively, while lifestyle changes have led to an increase in colorectal cancer cases.
This global health forecast underscores the urgent need for comprehensive strategies to combat the rising cancer burden worldwide.
The report dodged the issue of mRNA gene therapy COVID ‘vaccines’ as a possible cause of the increased rates. Researchers and experts have warned the toxic lipid nanoparticles (LNPs) and spike protein found in the COVID jabs, which health authorities said would remain localised to the injection site in the deltoid muscle, in fact travel throughout the body into every organ. A recent paper has called for ‘careful research’ into a potential link between COVID jabs and ‘turbo cancer’, while top world medical experts such as Yale epidemiologist Harvey Risch believes the explosion in cancer rates is directly related to the novel mRNA COVID gene therapy.
Image credit: National Cancer Institute (US)